USA - NASDAQ:UPXI - US39959A2050 - Common Stock
The current stock price of UPXI is 6.755 USD. In the past month the price decreased by -14.49%. In the past year, price increased by 73.56%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.73 | 154.20B | ||
KVUE | KENVUE INC | 17.75 | 36.44B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 55.77 | 30.10B | ||
ELF | ELF BEAUTY INC | 42.52 | 7.67B | ||
BRBR | BELLRING BRANDS INC | 17.54 | 4.80B | ||
COTY | COTY INC-CL A | 18.59 | 3.57B | ||
ODD | ODDITY TECH LTD-CL A | 29.49 | 3.51B | ||
IPAR | INTERPARFUMS INC | 20.84 | 3.43B | ||
EPC | EDGEWELL PERSONAL CARE CO | 8.41 | 1.01B | ||
YSG | YATSEN HOLDING LTD-ADR | N/A | 1.00B | ||
HLF | HERBALIFE LTD | 4.53 | 985.73M | ||
OLPX | OLAPLEX HOLDINGS INC | 17.75 | 947.25M |
Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 64 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
UPEXI INC
3030 Rocky Point Drive, Suite 420
Tampa FLORIDA US
Employees: 64
Phone: 17013535425
The current stock price of UPXI is 6.755 USD. The price increased by 18.93% in the last trading session.
The exchange symbol of UPEXI INC is UPXI and it is listed on the Nasdaq exchange.
UPXI stock is listed on the Nasdaq exchange.
8 analysts have analysed UPXI and the average price target is 15.81 USD. This implies a price increase of 134.05% is expected in the next year compared to the current price of 6.755. Check the UPEXI INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
UPEXI INC (UPXI) has a market capitalization of 342.41M USD. This makes UPXI a Small Cap stock.
UPEXI INC (UPXI) currently has 64 employees.
UPEXI INC (UPXI) has a support level at 6.04 and a resistance level at 7.56. Check the full technical report for a detailed analysis of UPXI support and resistance levels.
The Revenue of UPEXI INC (UPXI) is expected to decline by -83.67% in the next year. Check the estimates tab for more information on the UPXI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
UPXI does not pay a dividend.
UPEXI INC (UPXI) will report earnings on 2025-09-22, after the market close.
UPEXI INC (UPXI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-20.73).
The outstanding short interest for UPEXI INC (UPXI) is 24.45% of its float. Check the ownership tab for more information on the UPXI short interest.
ChartMill assigns a technical rating of 3 / 10 to UPXI. When comparing the yearly performance of all stocks, UPXI is one of the better performing stocks in the market, outperforming 79.04% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to UPXI. UPXI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months UPXI reported a non-GAAP Earnings per Share(EPS) of -20.73. The EPS decreased by -311.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -149.36% | ||
ROE | -1215.98% | ||
Debt/Equity | 0.31 |
8 analysts have analysed UPXI and the average price target is 15.81 USD. This implies a price increase of 134.05% is expected in the next year compared to the current price of 6.755.
For the next year, analysts expect an EPS growth of 30.61% and a revenue growth -83.67% for UPXI